Cargando…

Verifying a questionnaire diagnosis of asthma in children using health claims data

BACKGROUND: Childhood asthma prevalence is widely measured by parental proxy report of physician-diagnosed asthma in questionnaires. Our objective was to validate this measure in a North American population. METHODS: The 2884 study participants were a subsample of 5619 school children aged 5 to 9 ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Connie L, To, Teresa, Foty, Richard G, Stieb, David M, Dell, Sharon D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233499/
https://www.ncbi.nlm.nih.gov/pubmed/22108202
http://dx.doi.org/10.1186/1471-2466-11-52
Descripción
Sumario:BACKGROUND: Childhood asthma prevalence is widely measured by parental proxy report of physician-diagnosed asthma in questionnaires. Our objective was to validate this measure in a North American population. METHODS: The 2884 study participants were a subsample of 5619 school children aged 5 to 9 years from 231 schools participating in the Toronto Child Health Evaluation Questionnaire study in 2006. We compared agreement between "questionnaire diagnosis" and a previously validated "health claims data diagnosis". Sensitivity, specificity and kappa were calculated for the questionnaire diagnosis using the health claims diagnosis as the reference standard. RESULTS: Prevalence of asthma was 15.7% by questionnaire and 21.4% by health claims data. Questionnaire diagnosis was insensitive (59.0%) but specific (95.9%) for asthma. When children with asthma-related symptoms were excluded, the sensitivity increased (83.6%), and specificity remained high (93.6%). CONCLUSIONS: Our results show that parental report of asthma by questionnaire has low sensitivity but high specificity as an asthma prevalence measure. In addition, children with "asthma-related symptoms" may represent a large fraction of under-diagnosed asthma and they should be excluded from the inception cohort for risk factor studies.